Fortrea Holdings (FTRE) Cash & Current Investments (2022 - 2026)
Fortrea Holdings (FTRE) reported Cash & Current Investments of $147.5 million for Q1 2026, up 45.18% on a YoY basis from $101.6 million in Q1 2025, and down 15.52% quarter-over-quarter from $174.6 million in Q4 2025.
Fortrea Holdings (FTRE) Cash & Current Investments (2022 - 2026) Analysis & Trends
Fortrea Holdings has reported Cash & Current Investments for 5 years, with the latest figure at $147.5 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments rose 45.18% year-over-year to $147.5 million; the trailing twelve-month figure through Mar 2026 stood at $147.5 million (up 45.18% YoY), and the FY2025 full-year result was $174.6 million, up 47.34% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $147.5 million, down from $174.6 million in the prior quarter.
- The five-year high for Cash & Current Investments was $174.6 million in Q4 2025, with the low at $81.2 million in Q2 2025.
- Historically, Cash & Current Investments has averaged $117.0 million across 5 years, with a median of $112.0 million in 2022.
- The largest YoY upside for Cash & Current Investments was 47.34% in 2025 against a maximum downside of 35.66% in 2025.
- Fortrea Holdings' Cash & Current Investments stood at $112.0 million in 2022, then slipped by 3.04% to $108.6 million in 2023, then advanced by 9.12% to $118.5 million in 2024, then jumped by 47.34% to $174.6 million in 2025, then decreased by 15.52% to $147.5 million in 2026.
- The last three Cash & Current Investments figures came in at $147.5 million (Q1 2026), $174.6 million (Q4 2025), and $131.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.13 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn | 147.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 147.50 Mn |
| Dec 31, 2025 | 174.60 Mn |
| Sep 30, 2025 | 131.30 Mn |
| Jun 30, 2025 | 81.20 Mn |
| Mar 31, 2025 | 101.60 Mn |
| Dec 31, 2024 | 118.50 Mn |
| Sep 30, 2024 | 105.30 Mn |
| Jun 30, 2024 | 126.20 Mn |
| Mar 31, 2024 | 92.80 Mn |
| Dec 31, 2023 | 108.60 Mn |
| Sep 30, 2023 | 107.50 Mn |
| Jun 30, 2023 | 114.30 Mn |
| Dec 31, 2022 | 112.00 Mn |